Genetic Screening Visit

Similar documents
Policy Specific Section: Medical Necessity and Investigational / Experimental. October 15, 1997 October 9, 2013

Genetic Testing for BRCA1 and BRCA2 Genes

Genetic Testing for BRCA1 and BRCA2 Genes

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2

BRCA Precertification Information Request Form

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Policy and Procedure. Department: Utilization Management. SNP, CHP, MetroPlus Gold, Goldcare I&II, Market Plus, Essential, HARP

Eligibility criteria for prophylactic treatment allowance

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

patient education Fact Sheet

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas

POSITIVE DELETERIOUS MUTATION

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

BRCAplus. genetic testing for hereditary breast cancer

Precision Medicine and Genetic Counseling : Is Yes always the correct answer?

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Does Cancer Run in Your Family?

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER SYNDROME BRCA1 BRCA2

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Applies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans

MP Genetic Testing for BRCA1 or BRCA2 for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers

Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document.

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

GENETIC MANAGEMENT OF A FAMILY HISTORY OF BREAST AND / OR OVARIAN CANCER. Dr Abhijit Dixit. Family Health Clinical Genetics

PROVIDER POLICIES & PROCEDURES

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center

Primary Care Approach to Genetic Cancer Syndromes

The Importance of Iden0fying Women at Risk for BRCA1/2 Muta0ons for Referral to Cancer Gene0cs Services

Risk Assessment, Genetics, and Prevention

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team

HBOC. Jessica M. Salamone, ScM, CGC

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

WHAT DO GENES HAVE TO DO WITH IT? Breast Cancer Risk Assessment and Risk Reduction in 2016

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

Genetic Risk Assessment for Cancer

Result Navigator. Positive Test Result: RAD51C. After a positive test result, there can be many questions about what to do next. Navigate Your Results

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

GENETIC TESTING FOR HEREDITARY CANCER

BRCA2 gene. Associated Syndrome Name: Hereditary Breast and Ovarian Cancer syndrome (HBOC) BRCA2 Summary Cancer Risk Table. BRCA2 gene Overview

Outline. Identifying your risk for hereditary breast or ovarian cancer. Genetics 101. What causes cancer? Genetics

Genetic testing for hereditary cancer. An overview for healthcare providers

Genetic Risk Assessment for Cancer

Identification of patients suggestive of hereditary breast and ovarian cancer syndrome that warrants further professional evaluation.

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Result Navigator. Positive Test Result: STK11. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: CDH1. After a positive test result, there can be many questions about what to do next. Navigate Your Results

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC

Genetic Determinants, Risk Assessment and Management

Genetic Testing: who, what, why?

So, Who are the appropriate individuals that should consider genetic counseling and genetic testing?

OBJECTIVES 8/25/2017. An attempt to organize the chaos

Genetics and Cancer Care. Cynthia Forster-Gibson, MD, PhD and Loren Mackay- Loder, MSc Genetics Program, THP

Result Navigator. Positive Test Result: BMPR1A. After a positive test result, there can be many questions about what to do next. Navigate Your Results

This information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164.

BRCAnowTM It s Your Decision

Advice about familial aspects of breast cancer and epithelial ovarian cancer

Genomic/Genetic Services: Barriers to Access. Sue Friedman, DVM National Academies of Science Roundtable 06/26/18

I have ovarian cancer

Cancer Risk Assessment Questionnaire

CLINICAL MEDICAL POLICY

The Genetics of Breast and Ovarian Cancer Prof. Piri L. Welcsh

Please read the following instructions carefully

Result Navigator Positive Test Result: MSH6

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention

Result Navigator. Positive Test Result: PTEN. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Myriad Financial Assistance Program (MFAP)

PATIENT INFORMATION. (Last) (First) (Middle) (Last) (City) (State) (Zip)

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice

PATIENT AND GENETICS HEALTHCARE PROVIDER ATTITUDES REGARDING RECONTACT. Michelle Rose O Connor. BS, The Ohio State University, 2012

I have ovarian cancer

MP Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome (BRCA1 or BRCA2)

Corporate Medical Policy

A guide to genetic testing for hereditary cancers

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: CATEGORY: Laboratory Test

Factors Associated with Early Versus Late Development of Breast and Ovarian Cancer in BRCA1 and BRCA2 Positive Women

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

Clinical guideline Published: 25 June 2013 nice.org.uk/guidance/cg164

Hereditary Cancer Products

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Cancer Conversations

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

Transcription:

Before your visit In a typical hereditary breast ovarian cancer genetic counsling visit be prepared to answer the following set of questions, please check were applicable. About your self (same questions applies for your relatives below) Age at diagnosis of breast cancer, is it less than or equal 50 or more than 50 Male breast cancer if applicable Was the breast cancer triple negative, i.e Estrogen receptor negative, Progesterone receptor negative, and HER2 negative. Ovarian, fallopian tube, or primary peritoneal cancer. Bilateral breast cancer (both sides) diagnosed at same time or different times. Ashkenazi Jewish background /with breast or ovarian cancer. Pancreatic cancer if applicable. Prostate cancer if applicable About your immediate relatives such as parents, siblings, and children. About extended blood relative such as grandparents, aunts, uncles.

Risk assessment After providing all the above your health care provider will determine the appropriate genetic test for example limited testing to the previously identified mutations (founder mutation) limited panel. Please specify below. Extended panel. Please specify below Please be advised that testing may take up to 3 weeks to get results Results The result is usually categorized as one of the following, No mutation detected or Positive pathogenic variant or Variant of uncertain signficance

Below I will discuss general guidlines of the discussion that take place with provider specifically after finding a positive pathogenic variant. In summary, the finding of postive pathogenic variant result indicate increased risk for cancer. Your healthcare provide will then provide with early detection, risk reduction plan that will focus on the following main items, A. Breast awarness, including breast self-examination for both men and women. Please write details here. B. Imaging exams, e.g. mammogram, MRI or other. Please write details below C. Risk reduction strategy by medications and/or surgery. Please write details below. D. Family members, please consider sharing information with your family members so that they can also be seen by their healthcare providers for further recommendations

Genetic Testing Criteria for Hereditary Breast and Ovarian Cancer Syndrome (adapted from NCCN) An individual with ovarian cancer. An individual with breast cancer diagnosis meeting any of the following: A known mutation in a cancer susceptibiligy gene within family. Breast cancer diagnosed at age of 50 or less. Triple negative breast cancer diagnosed at age of 60 or less. Two breast primaries in a single individual. Breast cancer at any age, and 1 close blood relative with breast cancer 50 years, or 1 close blood relative with invasive ovarian cancer at any age, or 2 close blood relatives with breast cancer and/or pancreatic cancer at any age, or Pancreatic cancer at any age, or From a population at increased risk. Male breast cancer An individual of Ashkenazi Jewish descent with breast, ovarian or pancreatic cancer at any age An individual with a personal and/or family history of three or more of specific cancers (check with your provider for details) An individual with no personal history of cancer but with strong close family history of breast cancer, or ovarain cancer occuring at younger age, or male breast cancer. (check with your provider for details)

Questions Why do I need genetic testing? Do I have a hereditary breast and ovarian cancer (HBOC)? What specific gene I am tested for? Do I need extended testing beyond the above? How long will I have to wait for the results? Will insurance pay for genetic screening? What will the result mean for me and my treating team? What other tools and resources I can look on my own? I suggest you looking at the following please also consider checking the genetics resources in the link page here http:///links/ https://myriad.com/patients-families/patient-resources/ http://patients.ambrygen.com/cancer